Form 4: Aadi Bioscience Executive Chairman Neil Desai Sells 40,000 Shares

Neil Desai, Executive Chairman of Aadi Bioscience, Inc., sold 40,000 shares of common stock on September 3, 2024, at an average price of $1.7079.

Summary

• On September 3, 2024, Neil Desai, the Executive Chairman of Aadi Bioscience, Inc., sold 40,000 shares of the company's common stock.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
• The weighted average price for the shares sold was $1.7079, with prices ranging from $1.63 to $1.82.
• Following the transaction, Desai directly owns no shares, but indirectly owns 1,171,543 shares through the Anishka Family Trust and 639,698 shares through the Anishka Irrevocable 2016 Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders of a publicly traded company buy or sell the company's securities. These filings provide transparency into the transactions of company executives and directors.

Stakeholder Impact

• The stock sale by a key executive could be perceived negatively by some shareholders, potentially leading to concerns about the executive's confidence in the company's future prospects.

Key Dates